Abstract
Background: Although regular blood transfusion enhances the overall survival of
thalassaemia patients, it have a significant threat of infection with transfusion-related
infections, including hepatitis C; therefore, screening is mandatory. Routine screening with
anti-hepatitis C Ab was recommended many years ago; sometimes they depend on level of
liver enzymes.
Objective: To evaluate the clinical and biochemical features of seropositive hepatitis C
virus infection in multi-transfused β-thalassaemia patients to verify if they can be used as a
guidance for screening.
Patients and Methods: A retrospective- study done from June to September of 2014 at
Thalassaemia Center in Baqubah city - Diyala province - Iraq. All registered
β- thalassaemia major and intermedia patients were included, involving adults. Enzyme
linked immunosorbant assay was used to screen for hepatitis C virus. Symptoms, signs, and
biochemical features, including liver transaminases level, of sero-positive patients were
gathered and analyzed. Descriptive statistical analysis and Pearson chi- square test was
appliedto analyze data by using Statistical Package for Social Sciences software, version 16.
Results: The total enrolled subjects were 215, male gender comprises 54.9% (n=118); most
of the included patients were under 12 years old. The results indicate that 11.2%(n= 24) of
multi-transfused β- thalassaemia patients showed serological evidence of hepatitis C. The
highest anti-HCV prevalence was observed at ≥ 18 years old patients (p value=.000). More
than two third of cases were male gender (p value=.041), but the gender was not associated
with positive serology for hepatitis C in the whole sample of the study (p value=.096). All
anti-HCV positive patients were clinically asymptomatic; biochemically, 75% (n=18) of
them had normal liver transaminases levels (p value=. 014).
Conclusion: Asymptomatic clinical status and unreliable transaminases level elevation
cannot be helpful as directory for screening, we encourage the continuation of the usual
routine screening test by enzyme linked immunosorbant assay for hepatitis C in
β-thalassemia patients; it is more crucial for an older patient
thalassaemia patients, it have a significant threat of infection with transfusion-related
infections, including hepatitis C; therefore, screening is mandatory. Routine screening with
anti-hepatitis C Ab was recommended many years ago; sometimes they depend on level of
liver enzymes.
Objective: To evaluate the clinical and biochemical features of seropositive hepatitis C
virus infection in multi-transfused β-thalassaemia patients to verify if they can be used as a
guidance for screening.
Patients and Methods: A retrospective- study done from June to September of 2014 at
Thalassaemia Center in Baqubah city - Diyala province - Iraq. All registered
β- thalassaemia major and intermedia patients were included, involving adults. Enzyme
linked immunosorbant assay was used to screen for hepatitis C virus. Symptoms, signs, and
biochemical features, including liver transaminases level, of sero-positive patients were
gathered and analyzed. Descriptive statistical analysis and Pearson chi- square test was
appliedto analyze data by using Statistical Package for Social Sciences software, version 16.
Results: The total enrolled subjects were 215, male gender comprises 54.9% (n=118); most
of the included patients were under 12 years old. The results indicate that 11.2%(n= 24) of
multi-transfused β- thalassaemia patients showed serological evidence of hepatitis C. The
highest anti-HCV prevalence was observed at ≥ 18 years old patients (p value=.000). More
than two third of cases were male gender (p value=.041), but the gender was not associated
with positive serology for hepatitis C in the whole sample of the study (p value=.096). All
anti-HCV positive patients were clinically asymptomatic; biochemically, 75% (n=18) of
them had normal liver transaminases levels (p value=. 014).
Conclusion: Asymptomatic clinical status and unreliable transaminases level elevation
cannot be helpful as directory for screening, we encourage the continuation of the usual
routine screening test by enzyme linked immunosorbant assay for hepatitis C in
β-thalassemia patients; it is more crucial for an older patient
Keywords
β-thalassaemia
hepatitis C virus
serology
Keywords
الثلاسيميا β، فيروس التهاب الكبد C، علم الأمص